SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : dsco Discovery Laboratories

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gumbydamnit who wrote (13)4/22/1999 5:03:00 PM
From: wontgetfooledagin   of 318
 
Interesting post regarding jnj, abt relative to dsco and the details of the price protection of the financing on Yahoo message board by otter. JNJ not only owns 1.2+m in dsco but they have a royalty agreement of 10%.

He also said the price protection puts enormous pressure on mgt to get a deal done with in 5 months. For the price protection to have any detrimental effect to current shareholder 2 things have to happen. 1st the price of dsco has to average below $1.86 over a 5 week period prior to the end of the 5 month period. 2nd, management has to fail in securing a deal for over $10 million with a major pharma.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext